Category Archives: Articles

DevicePharm VP Christine Horton was a featured participant in a panel focused on leading and negotiating at “Women’s Executive Network Leadership Conference” sponsored by AdvaMed.

DevicePharm VP in Women’s Leadership Conference

Articles, Medical Device Marketing

On June 20, 2017, DevicePharm was represented with a featured group of business leaders in the “Women’s Executive Network Leadership Conference” sponsored by AdvaMed. The event, held in Boston, included an amazing group of medical device leaders. The attendance, which set a new event record, included participants ranging from large medical device organizations to emerging tech companies.

Read More
Austin office v2

DevicePharm Opens Austin, TX Office

Articles, Biotech Marketing

On May 1, 2017, DevicePharm announced the opening of our new office in Austin, Texas. This office was developed to serve the growing medical technology industry in Austin, Houston, Dallas, and San Antonio.

Clay Wilemon, DevicePharm CEO and Chief Strategy Officer described the motivation for opening the Austin office, “Texas has over 700 medical device, biotech, diagnostics, and pharmaceutical companies.

Read More
Agendia

46% Of High Risk Breast Cancer Patients May Not Require Chemo

Articles, Case Studies

Much-anticipated breast cancer results from the prospective, randomized clinical study known as MINDACT were published in the August 24, 2016 edition of the New England Journal of Medicine. The MINDACT study evaluated the MammaPrint® 70-Gene Breast Cancer Recurrence Assay in 6,693 patients to determine its ability to help physicians identify which early-stage breast cancer patients would, and would not, likely benefit from chemotherapy.

Read More
Provista_Logo_PMS

New Blood Test Accurately Detects the Presence or Absence of Breast Cancer

Articles, Biotech Marketing, Healthcare Marketing Strategies, Medical Marketing

At the 2015 San Antonio Breast Cancer Symposium, Provista introduced Videssa® Breast, a breakthrough that accurately detects the presence or absence of breast cancer with a protein-based blood test. Videssa® Breast provides clinicians, and their patients, with clinical confidence, clarity and peace-of-mind about what to do next when mammography is unclear – detecting the absence or presence of breast cancer by identifying early warning signals called biomarkers.

Read More